Join
Live feed
·
SECFilingvia Quantisnow
Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Creation of a Direct Financial Obligation

ByQuantisnow·Wall Street's wire, on your screen.
CNTA· Centessa Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTA (Centessa Pharmaceuticals plc) and more on Quantisnow.

Centessa Pharmaceuticals plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Creation of a Direct Financial Obligation | Quantisnow